Long-Term Imatinib Treatment for Patients with Unresectable or Recurrent Gastrointestinal Stromal Tumors-Reference-Cited by-同舟云学术

Long-Term Imatinib Treatment for Patients with Unresectable or Recurrent Gastrointestinal Stromal Tumors

Published:2018 Issue:1 Volume:97 Page:20-25
ISSN:0012-2823
Container-title:Digestion
language:en
Short-container-title:Digestion

Author:

Ogata Kyoichi,Kimura Akiharu,Nakazawa Nobuhiro,Suzuki Masaki,Yanoma Toru,Ubukata Yasunari,Iwamatsu Kiyohito,Kogure Norimichi,Yanai Mitsuhiro,Kuwano Hiroyuki

Publisher

S. Karger AG

Subject

Gastroenterology

Reference22 articles.

1. Hirota S, Isozaki K, Moriyama Y, et al: Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 1998; 279: 577–580.

2. Heinrich MC, Corless CL, Duensing A, et al: PDGFRA activating mutations in gastrointestinal stromal tumors. Science 2003; 299: 708–710.

3. Cameron S, Beham A, Schildhaus HU: Current standard and future perspectives in the treatment of gastrointestinal stromal tumors. Digestion 2017; 95: 262–268.

4. Demetri GD, von Mehren M, Blanke CD, et al: Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 2002; 347: 472–480.

5. Kanda T, Ishikawa T, Hirota S, et al: Prospective observational study of imatinib therapy in Japanese patients with advanced gastrointestinal stromal tumors: long-term follow-up and second malignancy. Jpn J Clin Oncol 2012; 42: 578–585.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gastrointestinal stromal tumours: incidence, recurrence and mortality. A decade of patients from a New Zealand tertiary surgical centre;ANZ Journal of Surgery;2024-08-16

2. Prediction for Plasma Trough Concentration and Optimal Dosing of Imatinib under Multiple Clinical Situations Using Physiologically Based Pharmacokinetic Modeling;ACS OMEGA;2023

3. Prediction for Plasma Trough Concentration and Optimal Dosing of Imatinib under Multiple Clinical Situations Using Physiologically Based Pharmacokinetic Modeling;ACS Omega;2023-04-03

4. 9.4 T static magnetic field ameliorates imatinib mesylate-induced toxicity and depression in mice;European Journal of Nuclear Medicine and Molecular Imaging;2022-09-27

5. Automated gathering of real-world data from online patient forums can complement pharmacovigilance for rare cancers;Scientific Reports;2022-06-20